» Articles » PMID: 26669699

PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer

Overview
Journal Cell Metab
Publisher Cell Press
Date 2015 Dec 17
PMID 26669699
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Cachexia is a wasting syndrome associated with elevated basal energy expenditure and loss of adipose and muscle tissues. It accompanies many chronic diseases including renal failure and cancer and is an important risk factor for mortality. Our recent work demonstrated that tumor-derived PTHrP drives adipose tissue browning and cachexia. Here, we show that PTH is involved in stimulating a thermogenic gene program in 5/6 nephrectomized mice that suffer from cachexia. Fat-specific knockout of PTHR blocked adipose browning and wasting. Surprisingly, loss of PTHR in fat tissue also preserved muscle mass and improved muscle strength. Similarly, PTHR knockout mice were resistant to cachexia driven by tumors. Our results demonstrate that PTHrP and PTH mediate wasting through a common mechanism involving PTHR, and there exists an unexpected crosstalk mechanism between wasting of fat tissue and skeletal muscle. Targeting the PTH/PTHrP pathway may have therapeutic uses in humans with cachexia.

Citing Articles

Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches.

Rahbar Saadat Y, Abbasi A, Hejazian S, Hekmatshoar Y, Ardalan M, Farnood F BMC Nephrol. 2025; 26(1):133.

PMID: 40069669 PMC: 11895341. DOI: 10.1186/s12882-025-04057-8.


Sarcopenia in Chronic Kidney Disease: A Narrative Review from Pathophysiology to Therapeutic Approaches.

Tsai C, Wang P, Hsiung T, Fan Y, Wu J, Kan W Biomedicines. 2025; 13(2).

PMID: 40002765 PMC: 11852367. DOI: 10.3390/biomedicines13020352.


Parathyroid hormone-related protein levels and treatment outcomes in hypercalcemia of malignancy: a retrospective cohort study.

Kato K, Nakashima A, Kimura A, Maruyama Y, Ohkido I, Miyazaki Y JBMR Plus. 2025; 9(3):ziae178.

PMID: 39925622 PMC: 11807284. DOI: 10.1093/jbmrpl/ziae178.


PTHrP Promotes RBP4 Expression Under the Control of PPARγ in the Kidney.

Nieto-Bona M, Carrasco A, Medina-Gomez G, Bosch R, Izquierdo-Lahuerta A Int J Mol Sci. 2025; 26(1.

PMID: 39795999 PMC: 11719952. DOI: 10.3390/ijms26010142.


Characteristics of lipid metabolism and fat distribution in patients with primary hyperparathyroidism and their Mendelian randomization study.

Zhang Y, Yang M, Wu Y, Wang Q Endocrine. 2024; .

PMID: 39702647 DOI: 10.1007/s12020-024-04141-3.


References
1.
Iguchi H, Onuma E, Sato K, Ogata E . Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int J Cancer. 2001; 94(1):24-7. DOI: 10.1002/ijc.1425. View

2.
Kobayashi T, Chung U, Schipani E, Starbuck M, Karsenty G, Katagiri T . PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development. 2002; 129(12):2977-86. DOI: 10.1242/dev.129.12.2977. View

3.
Jackson A, Shrikrishna D, Kelly J, Kemp S, Hart N, Moxham J . Vitamin D and skeletal muscle strength and endurance in COPD. Eur Respir J. 2012; 41(2):309-16. DOI: 10.1183/09031936.00043112. View

4.
Shellock F, Riedinger M, Fishbein M . Brown adipose tissue in cancer patients: possible cause of cancer-induced cachexia. J Cancer Res Clin Oncol. 1986; 111(1):82-5. DOI: 10.1007/BF00402783. View

5.
Tentori F, Wang M, Bieber B, Karaboyas A, Li Y, Jacobson S . Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2014; 10(1):98-109. PMC: 4284424. DOI: 10.2215/CJN.12941213. View